-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Prognostic Systems Masquerading As Staging Systems for Myelodysplastic Syndromes

Program: Special-Interest Sessions
Session: ASH/ASCP Summit on Myelodysplastic Syndromes
Saturday, December 5, 2015, 4:00 PM-5:30 PM
W230, Level 2 (Orange County Convention Center)

Mikkael A. Sekeres, MD, MS

Leukemia Program, Cleveland Clinic, Cleveland, OH

Disclosures: Sekeres: TetraLogic: Membership on an entity’s Board of Directors or advisory committees ; Celgene Corporation: Membership on an entity’s Board of Directors or advisory committees ; Amgen: Membership on an entity’s Board of Directors or advisory committees .

See more of: ASH/ASCP Summit on Myelodysplastic Syndromes
See more of: Special-Interest Sessions
Previous Presentation | Next Presentation >>